Calcium channel blockers modify jejunal uptake of D-galactose in rabbits

D. A. Hyson, A. B R Thomson, C. T. Kappagoda

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Calcium channel blockers modify the intestinal uptake of lipids. This study was undertaken to test the hypothesis that two different types of calcium channel blockers influence the uptake of D-galactose, a sugar absorbed by the sodium-dependent glucose transporter (SGLT1) in the intestinal brush border membrane. Nisoldipine (1 mg/kg/day) or verapamil (4 mg/kg/day) were given by mouth to New Zealand white rabbits for three weeks, and then the rates of uptake of varying concentrations (2-64 mM) of galactose were examined in an in vitro preparation of jejunum using the incorporation of 14C-labeled substrate into intact tissue segments. The maximal transport capacities (V(max)) for D-galactose were increased in animals given nisoldipine or verapamil, as compared to controls. The value of the apparent Michaelis constant (K(m)(*)) for D-galactose was higher with nisoldipine group and lower with verapamil, than in controls. The apparent passive permeability (P(d)(*)) of D-Galactose was estimated from the uptake of L-glucose: P(d)(*) was lower with nisoldipine and higher with verapamil, as compared to controls. The effect of these drugs on sugar uptake is not due to differences in the animals' food intake, body weight gain, or mucosal surface area. Thus, the two different classes of calcium channel blockers, the dihydropyridine nisoldipine and the phenylalkylamine verapamil, have different effects on the K(m)(*) and P(d)(*) but not on the V(max) of D-galactose uptake.

Original languageEnglish (US)
Pages (from-to)1871-1875
Number of pages5
JournalDigestive Diseases and Sciences
Volume41
Issue number9
StatePublished - 1996
Externally publishedYes

Fingerprint

Nisoldipine
Calcium Channel Blockers
Galactose
Verapamil
Rabbits
Sodium-Glucose Transport Proteins
Jejunum
Microvilli
Weight Gain
Mouth
Permeability
Eating
Body Weight
Lipids
Glucose
Membranes
Pharmaceutical Preparations

Keywords

  • Calcium channel blockers
  • Galactose
  • Glucose
  • Jejunal uptake
  • Nisoldipine
  • Verapamil

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Hyson, D. A., Thomson, A. B. R., & Kappagoda, C. T. (1996). Calcium channel blockers modify jejunal uptake of D-galactose in rabbits. Digestive Diseases and Sciences, 41(9), 1871-1875.

Calcium channel blockers modify jejunal uptake of D-galactose in rabbits. / Hyson, D. A.; Thomson, A. B R; Kappagoda, C. T.

In: Digestive Diseases and Sciences, Vol. 41, No. 9, 1996, p. 1871-1875.

Research output: Contribution to journalArticle

Hyson, DA, Thomson, ABR & Kappagoda, CT 1996, 'Calcium channel blockers modify jejunal uptake of D-galactose in rabbits', Digestive Diseases and Sciences, vol. 41, no. 9, pp. 1871-1875.
Hyson, D. A. ; Thomson, A. B R ; Kappagoda, C. T. / Calcium channel blockers modify jejunal uptake of D-galactose in rabbits. In: Digestive Diseases and Sciences. 1996 ; Vol. 41, No. 9. pp. 1871-1875.
@article{06a531e7b31341d696bea8f114f50d29,
title = "Calcium channel blockers modify jejunal uptake of D-galactose in rabbits",
abstract = "Calcium channel blockers modify the intestinal uptake of lipids. This study was undertaken to test the hypothesis that two different types of calcium channel blockers influence the uptake of D-galactose, a sugar absorbed by the sodium-dependent glucose transporter (SGLT1) in the intestinal brush border membrane. Nisoldipine (1 mg/kg/day) or verapamil (4 mg/kg/day) were given by mouth to New Zealand white rabbits for three weeks, and then the rates of uptake of varying concentrations (2-64 mM) of galactose were examined in an in vitro preparation of jejunum using the incorporation of 14C-labeled substrate into intact tissue segments. The maximal transport capacities (V(max)) for D-galactose were increased in animals given nisoldipine or verapamil, as compared to controls. The value of the apparent Michaelis constant (K(m)(*)) for D-galactose was higher with nisoldipine group and lower with verapamil, than in controls. The apparent passive permeability (P(d)(*)) of D-Galactose was estimated from the uptake of L-glucose: P(d)(*) was lower with nisoldipine and higher with verapamil, as compared to controls. The effect of these drugs on sugar uptake is not due to differences in the animals' food intake, body weight gain, or mucosal surface area. Thus, the two different classes of calcium channel blockers, the dihydropyridine nisoldipine and the phenylalkylamine verapamil, have different effects on the K(m)(*) and P(d)(*) but not on the V(max) of D-galactose uptake.",
keywords = "Calcium channel blockers, Galactose, Glucose, Jejunal uptake, Nisoldipine, Verapamil",
author = "Hyson, {D. A.} and Thomson, {A. B R} and Kappagoda, {C. T.}",
year = "1996",
language = "English (US)",
volume = "41",
pages = "1871--1875",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "9",

}

TY - JOUR

T1 - Calcium channel blockers modify jejunal uptake of D-galactose in rabbits

AU - Hyson, D. A.

AU - Thomson, A. B R

AU - Kappagoda, C. T.

PY - 1996

Y1 - 1996

N2 - Calcium channel blockers modify the intestinal uptake of lipids. This study was undertaken to test the hypothesis that two different types of calcium channel blockers influence the uptake of D-galactose, a sugar absorbed by the sodium-dependent glucose transporter (SGLT1) in the intestinal brush border membrane. Nisoldipine (1 mg/kg/day) or verapamil (4 mg/kg/day) were given by mouth to New Zealand white rabbits for three weeks, and then the rates of uptake of varying concentrations (2-64 mM) of galactose were examined in an in vitro preparation of jejunum using the incorporation of 14C-labeled substrate into intact tissue segments. The maximal transport capacities (V(max)) for D-galactose were increased in animals given nisoldipine or verapamil, as compared to controls. The value of the apparent Michaelis constant (K(m)(*)) for D-galactose was higher with nisoldipine group and lower with verapamil, than in controls. The apparent passive permeability (P(d)(*)) of D-Galactose was estimated from the uptake of L-glucose: P(d)(*) was lower with nisoldipine and higher with verapamil, as compared to controls. The effect of these drugs on sugar uptake is not due to differences in the animals' food intake, body weight gain, or mucosal surface area. Thus, the two different classes of calcium channel blockers, the dihydropyridine nisoldipine and the phenylalkylamine verapamil, have different effects on the K(m)(*) and P(d)(*) but not on the V(max) of D-galactose uptake.

AB - Calcium channel blockers modify the intestinal uptake of lipids. This study was undertaken to test the hypothesis that two different types of calcium channel blockers influence the uptake of D-galactose, a sugar absorbed by the sodium-dependent glucose transporter (SGLT1) in the intestinal brush border membrane. Nisoldipine (1 mg/kg/day) or verapamil (4 mg/kg/day) were given by mouth to New Zealand white rabbits for three weeks, and then the rates of uptake of varying concentrations (2-64 mM) of galactose were examined in an in vitro preparation of jejunum using the incorporation of 14C-labeled substrate into intact tissue segments. The maximal transport capacities (V(max)) for D-galactose were increased in animals given nisoldipine or verapamil, as compared to controls. The value of the apparent Michaelis constant (K(m)(*)) for D-galactose was higher with nisoldipine group and lower with verapamil, than in controls. The apparent passive permeability (P(d)(*)) of D-Galactose was estimated from the uptake of L-glucose: P(d)(*) was lower with nisoldipine and higher with verapamil, as compared to controls. The effect of these drugs on sugar uptake is not due to differences in the animals' food intake, body weight gain, or mucosal surface area. Thus, the two different classes of calcium channel blockers, the dihydropyridine nisoldipine and the phenylalkylamine verapamil, have different effects on the K(m)(*) and P(d)(*) but not on the V(max) of D-galactose uptake.

KW - Calcium channel blockers

KW - Galactose

KW - Glucose

KW - Jejunal uptake

KW - Nisoldipine

KW - Verapamil

UR - http://www.scopus.com/inward/record.url?scp=0029783623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029783623&partnerID=8YFLogxK

M3 - Article

C2 - 8794809

AN - SCOPUS:0029783623

VL - 41

SP - 1871

EP - 1875

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 9

ER -